Lutropin alfa vs Buserelin

Head-to-head comparison of Lutropin alfa (Recombinant Human Luteinizing Hormone Alfa) and Buserelin (Buserelin acetate) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyLutropin alfaBuserelin
CategorySexual HealthSexual Health
Full NameRecombinant Human Luteinizing Hormone AlfaBuserelin acetate
Molecular Weight30,000 Da1239.39 Da
Half-Life~10-12 hours~50-80 minutes
Amino AcidsN/A9
Typical Dose75-150 IU per dose200 mcg intranasal 3x daily|0.2-0.5 mg SC daily|depot per protocol
RouteSubcutaneous/IntramuscularIntranasal/Subcutaneous
Purity≥98%≥98%
Studies Count420450
Research StatusClinicalClinical

Lutropin alfa Benefits

  • stimulates Leydig cells
  • raises endogenous testosterone
  • supports testicular steroidogenesis
  • pairs with FSH for fertility

Buserelin Benefits

  • pituitary down-regulation
  • cycle synchronization
  • ovarian stimulation control
  • fertility protocol timing

Lutropin alfa Dosing

75-150 IU SC/IM 2-3x weekly|adjust to testosterone response|combine with FSH when spermatogenesis support is needed

Buserelin Dosing

200 mcg intranasal 3x daily|0.2-0.5 mg SC daily|depot injection per protocol

Lutropin alfa Side Effects

  • injection-site reactions
  • headache
  • hormonal swings

Buserelin Side Effects

  • hot flashes
  • headache
  • initial LH/FSH flare

Research Overview

Lutropin alfa

Lutropin alfa has been evaluated in fertility protocols to restore LH signaling and endogenous testosterone production. It is a direct research/clinical analogue for men with low gonadotropin drive.

Buserelin

Buserelin has been studied extensively as a GnRH agonist in IVF down-regulation and other reproductive-endocrine protocols. Its use helped establish modern cycle-control approaches in assisted reproduction.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Lutropin alfa stacks with:

Follitropin alfahCG

Buserelin stacks with:

FSHhCG
LHtestosteronefertilityclinicalGnRH-agonistivf